The making of memory B cells and lon... - Lung Conditions C...

Lung Conditions Community Forum

56,314 members66,939 posts

The making of memory B cells and long-term immune responses.

2greys profile image
5 Replies

The current COVID-19 climate has made vaccines, antibodies, and immune responses topics of everyday conversation. Now, it isn’t just immunologists who want to know how our bodies respond to re-infections months, years, or sometimes decades after an initial immune response. A new study by Tomohiro Kurosaki at Osaka University shows that this ability requires Bach2, a protein that regulates the expression of genes needed to instruct activated B cells under selection to become memory B cells.

Like most biological processes, immune responses are complicated. They involve numerous types of cells and proteins, performing precise step-by-step processes. And of course, we don’t know all of them yet. For example, memory B cells are a type of white blood cell that are created in lymph nodes or spleens during an infection. They stick around for years and allow rapid and strong antibody-related responses to re-infection by the same virus or bacteria. In contrast, plasma cells are much more numerous and help during an initial infection by producing antibodies, although they too can exist for long periods of time in the body. Kurosaki and his team focused their research on understanding what causes activated B cells, called germinal center B cells, to become memory B cells, plasma cells, or to be recycled.

resou.osaka-u.ac.jp/en/rese...

Journal of Experimental Medicine. The research paper:

rupress.org/jem/article/218...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
5 Replies
2greys profile image
2greys

A plausible explanation of why certain people have experienced a reinfection of Covid-19, as small a percentage worldwide. An anomaly in their immune system preventing the production of memory B cells.

tomhatha profile image
tomhatha

What happened to the mild Flu that was made to look like the Covid ( rods put on it so that it looked like cov-19, the immune system saw it and remembered it . the rest results said it worked and they were ready to fight and kill the covid ? That worked in all trials. it seems to me it has gone where a lot of things go (put on hold for some reason) just like the cancer one where medication is put into micro bubbles and burst over the cancer AND WOMAN DID NOT LOOSE THEIR HAIR or have bad feelings?

2greys profile image
2greys in reply totomhatha

Who knows what has happened. What I do know for an absolute fact is that flu is caused by the Influenza Virus, not a Coronavirus, a wolf in sheep's clothing is still a wolf. It could have been a means to attract 'investment' money (you can make the rest up from that).

tomhatha profile image
tomhatha in reply to2greys

the two things I mentioned Did work and were tested . They never asked for money .

2greys profile image
2greys in reply totomhatha

It still remains a wolf in sheep's clothing, there is more to a vaccine than the protein spikes unfortunately, stimulating antibody production against those spikes may well work but they will only last for a finite time. Nobody wants to be vaccinated every 3 to four months, it would also not be practical, the logistics to that would also be formidable.

The real trick is the production of B and T cells as well that are very important, it is these that last longer and will produce more antibodies as well as kill infected cells. It is the bodies own cells that reproduce the virus by many times. Kill the infected cells and the virus cannot reproduce.

Not what you're looking for?

You may also like...

Immunological memory after SARS-CoV-2 infection recovery. *The welcome news we have been waiting for*

Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to a persistent...
2greys profile image

Article list.

The devil's tic tacks well and truly kicked in. Vertigo, from left ear damage, perforated ear drum,...
2greys profile image

Phase 2/3 trial of Oxford COVID-19 vaccine in healthy older adults finds it is safe and provokes immune response.

The UK's vaccine against SARS-CoV-2 shows similar safety and immunogenicity results in healthy...
2greys profile image

Common IBS/IBD treatment blunts COVID-19 vaccine response.

People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume...
2greys profile image

The immune system: Knocked off balance.

Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune...
2greys profile image

Moderation team

See all
AsthmaandLung profile image
AsthmaandLungAdministrator
moderator_AandLUK profile image
moderator_AandLUKAdministrator
Claire_ALUK profile image
Claire_ALUKAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.